Avantor, Inc.

NYSE:AVTR

Medical - Instruments & Supplies

Healthcare
$15.37 +0.69%

+$0.07 today

Market cap
$10.41B
Beta
0.96
P/E (TTM)
-11.7
EPS (TTM)
-$0.81
52W Low $7.27High $15.93

Volume 5.94M

Average 9.44M

AVTR Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Avantor, Inc.NYSE: AVTR

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares declines year over year

Q2 FY2026 weighted avg shares of 676.2M shares fell 0.8% year over year, in line with the -0.4% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.3% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -0.8% toward the trailing-twelve-month pace of -0.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
676.2M-0.3% QoQ
Last fiscal yearDec 2025
678M-0.3% YoY
LTMJun 2026
678.48M-0.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.8%——
1 year-0.3%——
3-year CAGR+1.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
678M USD
Year-over-year change
-0.3%
4-year CAGR
+3.5%

Weighted Avg Shares vs competitors

How AVTR compares with its peers on the latest reported figures

  • AVTR's LTM Jun 2026 weighted avg shares of 678.48M shares is the 2nd highest of the 9 companies compared; the peer median is 52.67M shares.
  • Its year-over-year change of -0.4% is the 4th highest of 9, against a peer median of -1.2%.
  • Over three fiscal years its annual growth of +1.4% compares with a peer median of -0.8%.
AVTR Competitors Peer median
Weighted Avg Shares for AVTR and competitors
Company Period LTM YoY 3-year CAGR
DHRDanaher CorporationLTM Sep 2026706.08M -1.7%-0.8%
AVTRAvantor, Inc.LTM Jun 2026678.48M -0.4%+1.4%
STVNStevanato Group S.p.A.LTM Jun 2026273M +0.0%+1.0%
WSTWest Pharmaceutical Services, Inc.LTM Jun 202671.85M -1.1%-0.9%
RGENRepligen CorporationLTM Jun 202656.37M +0.5%+0.5%
CRLCharles River Laboratories International, Inc.LTM Jun 202648.97M -3.2%-0.8%
BLFSBioLife Solutions, Inc.LTM Mar 202647.98M +3.2%+4.0%
AZTAAzenta, Inc.LTM Sep 202645.14M -1.3%-12.0%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.9M -3.2%-2.9%
Peer median (excluding AVTR) 52.67M-1.2%-0.8%

Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue7.39B7.51B6.97B6.78B6.55B
Cost of Revenue4.88B4.91B4.6B4.5B4.41B
Gross Profit2.5B2.6B2.36B2.28B2.14B
Gross Margin33.9%34.6%33.9%33.6%32.7%
Research & Development00000
Selling, General & Admin1.53B1.47B1.51B1.64B1.6B
Operating Expenses1.53B1.47B1.67B1.19B2.39B
Depreciation & Amortization379.2M405.5M402.3M405.5M410.2M
EBITDA1.35B1.52B1.1B1.48B138.7M
EBITDA Margin18.3%20.3%15.8%21.8%2.1%
Operating Income972.2M1.13B696.4M1.08B(246.2M)
Operating Margin13.2%15.0%10.0%16.0%-3.8%
Interest Income00000
Interest Expense217.4M265.8M284.8M218.8M169.8M
Other Income / Expenses(219.2M)(279.1M)(285.9M)(230.9M)(195.1M)
Income Before Tax753M851.1M410.5M853.9M(441.3M)
Pre-Tax Margin10.2%11.3%5.9%12.6%-6.7%
Income Tax Expense180.4M164.6M89.4M142.4M88.9M
Net Income572.6M686.5M321.1M711.5M(530.2M)
Net Margin7.8%9.1%4.6%10.5%-8.1%
EPS (Basic)0.861.020.481.05(0.78)
EPS (Diluted)0.851.010.471.04(0.78)
Weighted Avg Shares590.5M650.9M675.6M680.3M678M
Weighted Avg Shares (Diluted)599.6M679.4M678.4M681.9M679.3M

Avantor, Inc.

NYSE:AVTR

Intrinsic Alpha fair value

Locked

Current Price

$15.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.